National Influenza Mid-Season Report, 2019-2020.

Canada's national influenza season started in week 47 between November 17 to 23, 2019. Of the 3,762 laboratory-confirmed influenza detections reported from August 25 to December 14, 2019, 61% were influenza A, and of those subtyped, 68% were A(H3N2). Influenza B detections are above average for this time of year. Indicators of influenza activity are within the expected range for this time of year. The majority of hospitalizations reported by provinces and territories have been associated with influenza A(H3N2) (76%), and the greatest proportion have been among adults 65 years and older (40%). Among sentinel pediatric influenza hospitalizations, 55% were associated with influenza B and the majority have been under five years of age (63%). Antigenic and genetic characterization results to date suggest that the majority of circulating A(H3N2) and B viruses are not similar to the virus components recommended for use in the 2019-2020 seasonal influenza vaccines and that the majority of circulating A(H1N1) viruses are similar to the vaccine reference strains.

[1]  D. Skowronski,et al.  Guidance on the use of antiviral agents for the 2019-2020 influenza season. , 2020, Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada.

[2]  D. Schanzer,et al.  Leading Indicators and the Evaluation of the Performance of Alerts for Influenza Epidemics , 2015, PloS one.

[3]  Baltazar Nunes,et al.  Influenza surveillance in Europe: establishing epidemic thresholds by the Moving Epidemic Method , 2012, Influenza and other respiratory viruses.

[4]  Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season. , 2014, Releve epidemiologique hebdomadaire.

[5]  R. Jorge Influenza surveillance in Europe: establishing epidemic thresholds by the Moving Epidemic Method , 2012 .